Commentary: Predicting future coronary heart disease deaths in Finland and elsewhere
Open Access
- 17 July 2006
- journal article
- editorial
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 35 (5) , 1253-1254
Abstract
Globally, cardiovascular disease will remain the dominant cause of death and disability in the next few decades. In Finland, and in many other industrialized countries, age-adjusted coronary heart disease (CHD) mortality rates have halved recently, mainly as a result of reductions in major risk factors (cholesterol, smoking, and blood pressure), plus additional gains from medical treatments.1 The pressing question is: given demographic ageing, what is going to happen to disease prevalence and, hence, the population burden of disease?Keywords
This publication has 13 references indexed in Scilit:
- Predicting coronary heart disease mortality—assessing uncertainties in population forecasts and death probabilities by using Bayesian inferenceInternational Journal of Epidemiology, 2006
- Preventing coronary heart diseaseBMJ, 2006
- Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patientsHeart, 2006
- Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997American Journal of Epidemiology, 2005
- Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortalityJournal of Clinical Epidemiology, 2005
- Cardiovascular health and economic effects of smoke-free workplacesThe American Journal of Medicine, 2004
- Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular diseaseEuropean Heart Journal, 2004
- Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in ScotlandEuropean Heart Journal, 2000
- Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populationsThe Lancet, 1999
- Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?BMJ, 1991